Employees: 03 (2023.0)Legal category: 5785Size: PMECreation date: 2018-11-01 (7 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: MARSEILLE (13008), Bouches-du-Rhone
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELAS PHARMACIE BORELY : revenue, balance sheet and financial ratios
SELAS PHARMACIE BORELY is a French company
founded 7 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MARSEILLE (13008),
this company of category PME
shows in 2025 a net income negative of -35 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELAS PHARMACIE BORELY (SIREN 843119975)
Indicator
2025
2024
2022
2020
Revenue
N/C
N/C
N/C
N/C
Net income
-35 104 €
69 897 €
253 480 €
176 195 €
EBITDA
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, SELAS PHARMACIE BORELY records a net loss of 35 k€. This deficit will reduce equity on the balance sheet.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
-35 104 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 100%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 44%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
99.515%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
44.366%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2020
2022
2024
2025
Debt ratio
275.702
85.537
58.366
99.515
Financial autonomy
23.892
47.754
57.553
44.366
Repayment capacity
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
Sector positioning
Debt ratio
99.522025
2022
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Average+13 pts over 3 years
In 2025, the debt ratio of SELAS PHARMACIE BORELY (99.52) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
44.37%2025
2022
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Average-12 pts over 3 years
In 2025, the financial autonomy of SELAS PHARMACIE BORELY (44.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 258.60. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2020
2022
2024
2025
Liquidity ratio
257.502
269.498
365.739
258.599
Interest coverage
None
None
None
None
Sector positioning
Liquidity ratio
258.62025
2022
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Excellent
In 2025, the liquidity ratio of SELAS PHARMACIE BORELY (258.60) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Positioning of SELAS PHARMACIE BORELY in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELAS PHARMACIE BORELY with other companies in the same sector:
Frequently asked questions about SELAS PHARMACIE BORELY
What is the revenue of SELAS PHARMACIE BORELY ?
The revenue of SELAS PHARMACIE BORELY is not publicly disclosed (confidential accounts filed with INPI).
Is SELAS PHARMACIE BORELY profitable?
SELAS PHARMACIE BORELY recorded a net loss in 2025.
Where is the headquarters of SELAS PHARMACIE BORELY ?
The headquarters of SELAS PHARMACIE BORELY is located in MARSEILLE (13008), in the department Bouches-du-Rhone.
Where to find the tax return of SELAS PHARMACIE BORELY ?
The tax return of SELAS PHARMACIE BORELY is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELAS PHARMACIE BORELY operate?
SELAS PHARMACIE BORELY operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart